Details for New Drug Application (NDA): 202285
✉ Email this page to a colleague
The generic ingredient in OLANZAPINE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.
Summary for 202285
Tradename: | OLANZAPINE |
Applicant: | Mylan |
Ingredient: | olanzapine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 202285
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 202285 | ANDA | Mylan Pharmaceuticals Inc. | 0378-5510 | 0378-5510-93 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0378-5510-93) |
OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 202285 | ANDA | Mylan Pharmaceuticals Inc. | 0378-5511 | 0378-5511-93 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0378-5511-93) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 5MG | ||||
Approval Date: | May 12, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
Approval Date: | May 12, 2014 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 15MG | ||||
Approval Date: | May 12, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription